translation agency

AIDS Treatment News
California: New Drugs Added to AIDS Drug Assistance Program
John S. James
May 19, 1995
AIDS TREATMENT NEWS Issue #223, May 19, 1995

In March 1995, 18 new drugs were added to the California AIDS Drug Assistance Program; these are in addition to the 25 drugs already there. These drugs can be fully or partially reimbursed for persons with HIV with moderate incomes. Funding is from the Federal Ryan White Title II program.

The following drugs are now in the program (the asterisk indicates the new additions): acyclovir, alpha interferon*, amphotericin B, atovaquone, azithromycin, bleomycin sulfate*, clarithromycin, clindamycin, clofazimine, clotrimazole, cyclophosphamide*, dapsone, ddC, ddI, dexamethasone*, doxorubicin*, dronabinol*, epoetin alfa*, ethambutol, filgrastim*, fluconazole, flucytosine, foscarnet, ganciclovir, itraconazole*, ketoconazole, leucovorin calcium*, megestrol acetate*, methotrexate*, nystatin, paromomycin, pentamidine, prednisone*, pyrimethamine, rifabutin, stavudine*, sulfadiazine, trimethoprim*, trimethoprim-sulfamethoxazole, trimetrexate glucuronate*, vinblastine sulfate*, vincristine sulfate*, zidovudine (AZT). Note: The new oral ganciclovir has also been added to the formulary.

Comment New drugs could be added at this time because of reduced expenditures for AZT, often due to the widespread discouragement about treatment caused by misinterpretation of the European Concorde study, which was published in April 1993. That study legitimately raised doubt about certain early uses of AZT, but was widely misunderstood as meaning that HIV treatment did not work.